LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis

Yu Li, Liqin Wang, Xiaoyi Xu, Heng Sun, Leilei Wu

Open source

DOI
10.2147/cmar.s329846
Published
2021-10
Container
Cancer Management and Research
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/cmar.s329846,
  title = {LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis},
  author = {Yu Li and Liqin Wang and Xiaoyi Xu and Heng Sun and Leilei Wu},
  year = {2021},
  journal = {Cancer Management and Research},
  doi = {10.2147/cmar.s329846},
  url = {https://doi.org/10.2147/cmar.s329846}
}

RIS

TY  - JOUR
TI  - LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis
AU  - Yu Li
AU  - Liqin Wang
AU  - Xiaoyi Xu
AU  - Heng Sun
AU  - Leilei Wu
PY  - 2021
JO  - Cancer Management and Research
DO  - 10.2147/cmar.s329846
UR  - https://doi.org/10.2147/cmar.s329846
ER  - 

APA

Li, Y., Wang, L., Xu, X., Sun, H., & Wu, L. (2021). LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis. Cancer Management and Research. https://doi.org/10.2147/cmar.s329846

Source records